399 related articles for article (PubMed ID: 25830296)
1. Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
Belknap SM; Aslam I; Kiguradze T; Temps WH; Yarnold PR; Cashy J; Brannigan RE; Micali G; Nardone B; West DP
JAMA Dermatol; 2015 Jun; 151(6):600-6. PubMed ID: 25830296
[TBL] [Abstract][Full Text] [Related]
2. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.
Liu L; Zhao S; Li F; Li E; Kang R; Luo L; Luo J; Wan S; Zhao Z
J Sex Med; 2016 Sep; 13(9):1297-1310. PubMed ID: 27475241
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
Sato A; Takeda A
J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
[TBL] [Abstract][Full Text] [Related]
4. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.
Rossi A; Cantisani C; Scarnò M; Trucchia A; Fortuna MC; Calvieri S
Dermatol Ther; 2011; 24(4):455-61. PubMed ID: 21910805
[TBL] [Abstract][Full Text] [Related]
5. Androgenetic alopecia; drug safety and therapeutic strategies.
Motofei IG; Rowland DL; Baconi DL; Tampa M; Sârbu MI; Păunică S; Constantin VD; Bălălău C; Păunică I; Georgescu SR
Expert Opin Drug Saf; 2018 Apr; 17(4):407-412. PubMed ID: 29363345
[TBL] [Abstract][Full Text] [Related]
6. Guidelines on the use of finasteride in androgenetic alopecia.
Mysore V; Shashikumar BM
Indian J Dermatol Venereol Leprol; 2016; 82(2):128-34. PubMed ID: 26924401
[TBL] [Abstract][Full Text] [Related]
7. Finasteride and androgenic alopecia; from therapeutic options to medical implications.
Motofei IG; Rowland DL; Tampa M; Sarbu MI; Mitran MI; Mitran CI; Stoian AP; Diaconu CC; Paunica S; Georgescu SR
J Dermatolog Treat; 2020 Jun; 31(4):415-421. PubMed ID: 30897009
[TBL] [Abstract][Full Text] [Related]
8. A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation.
Cecchin E; De Mattia E; Mazzon G; Cauci S; Trombetta C; Toffoli G
Int J Biol Markers; 2014 Dec; 29(4):e310-6. PubMed ID: 24855036
[TBL] [Abstract][Full Text] [Related]
9. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
Coskuner ER; Ozkan B; Culha MG
Sex Med Rev; 2019 Apr; 7(2):277-282. PubMed ID: 30301703
[TBL] [Abstract][Full Text] [Related]
10. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
Jung JY; Yeon JH; Choi JW; Kwon SH; Kim BJ; Youn SW; Park KC; Huh CH
Int J Dermatol; 2014 Nov; 53(11):1351-7. PubMed ID: 24898559
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients.
Moreno-Arrones OM; Becerra A; Vano-Galvan S
Clin Exp Dermatol; 2017 Oct; 42(7):743-748. PubMed ID: 28691187
[TBL] [Abstract][Full Text] [Related]
12. 5α-Reductase inhibitors in androgenetic alopecia.
Yim E; Nole KL; Tosti A
Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):493-8. PubMed ID: 25268732
[TBL] [Abstract][Full Text] [Related]
13. Oral Finasteride Presents With Sexual-Unrelated Withdrawal in Long-Term Treated Androgenic Alopecia in Men.
Perez-Mora N; Velasco C; Bermüdez F
Skinmed; 2015; 13(3):179-83. PubMed ID: 26380503
[TBL] [Abstract][Full Text] [Related]
14. Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study.
Ali AK; Heran BS; Etminan M
Pharmacotherapy; 2015 Jul; 35(7):687-95. PubMed ID: 26133534
[TBL] [Abstract][Full Text] [Related]
15. Are hand preference and sexual orientation possible predicting factors for finasteride adverse effects in male androgenic alopecia?
Motofei IG; Rowland DL; Georgescu SR; Tampa M; Baleanu BC; Paunica S
Exp Dermatol; 2016 Jul; 25(7):557-8. PubMed ID: 26990657
[TBL] [Abstract][Full Text] [Related]
16. Finasteride and Suicide: A Postmarketing Case Series.
Irwig MS
Dermatology; 2020; 236(6):540-545. PubMed ID: 31935720
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic hotline. Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
Lynn R; Krunic A
Dermatol Ther; 2010; 23(5):544-6. PubMed ID: 20868409
[TBL] [Abstract][Full Text] [Related]
18. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).
Shapiro J; Kaufman KD
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):20-3. PubMed ID: 12894990
[TBL] [Abstract][Full Text] [Related]
19. Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: A Review.
Seale LR; Eglini AN; McMichael AJ
J Drugs Dermatol; 2016 Apr; 15(4):414-9. PubMed ID: 27050696
[TBL] [Abstract][Full Text] [Related]
20. Persistent sexual side effects of finasteride for male pattern hair loss.
Irwig MS; Kolukula S
J Sex Med; 2011 Jun; 8(6):1747-53. PubMed ID: 21418145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
